About us, and our mission


Less than 5% of new cancer drugs successfully make it through clinical trials. Clearly, new methods are needed to transform oncology research and improve patient care. Orakl Oncology is a techbio startup accelerating drug discovery and development through innovative tumor avatars. The company was established in 2023 as a spin-out from Gustave-Roussy, a leading European cancer research institute based on 10 years of research by Orakl’s CEO, Dr. Fanny Jaulin, and her laboratory.

Orakl Oncology is pioneering the use of its patient tumor avatar ****technology to anticipate clinical trial outcomes. We create an avatar for each patient’s tumor, combining clinical and molecular data alongside proprietary organoids, at scale, and predict patient response in the clinic. Powered by lab automation and machine learning, we discover and validate new targets, drugs, and predictive biomarkers. The VC-backed company is growing fast, and we are now seeking the best talents to come and join our exciting and ambitious team in the fight against cancer!

To know more about Orakl and our job offers: Careers on Orakl's website.

The position


Orakl Oncology is a pioneering startup at the forefront of the techbio, blending computation & biology in oncology. We are a tight-knit, passionate team dedicated to advancing science and developing innovative solutions to transform anti-cancer drug development.

This is an exciting opportunity for a Business Development professional with a proven background in building partnerships in the USA and EU to create a strategy, lead a business development life cycle, and secure partnerships. These partnerships will be focused on biopharma companies, emerging biotechs, and academic institutions, with a focus on Oncology Clinical Trials.

We are focused on partnerships that utilize a combination of ex vivo and molecular testing, designed to help pharmaceutical and biotech companies speed up their R&D process, reduce costs, and increase the chances of bringing more effective oncology drugs to market. This is a unique model, already creating traction and a building pipeline.

Reporting directly to the CEO, you will play a pivotal role in spearheading business development and partnership strategies, contributing significantly to the company's growth.

You can be based in the EU/UK or in the USA, and must have the proven background of building and securing partnerships in the USA. The role will involve travel to Paris and the USA often.

Responsibilities and key skills required for the role